| Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine. | |
| | |
MedLine Citation:
|
PMID: 12771475 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We report the case of a 61-year-old woman who developed an anaplastic CD30+ cutaneous T-cell lymphoma during oral cyclosporine (CsA) therapy for recalcitrant psoriasis. Two months after CsA discontinuation, clinical and histological resolution of the lymphoma was observed. However, 3 years later extracutaneous involvement of the lymphoma could be detected. The association between CsA administration and the occurrence of the lymphoma may be casual, but a relationship with immunosuppression may also be hypothesized. We have reviewed all relevant data in the literature. To our knowledge, this is the first case of primary cutaneous CD30+ anaplastic large T-cell lymphoma in a patient treated with CsA for psoriasis. |
| | |
Authors:
|
M Corazza; M R Zampino; A Montanari; E Altieri; A Virgili |
Related Documents
:
|
11421295 - Successful treatment of paraneoplastic pemphigus in follicular nhl with rituximab: repo... 9267825 - Cd23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemia... 6404945 - Middle eastern intestinal lymphoma: a morphological and immunohistochemical study. 2649225 - Hypercalcemia and vitamin d metabolism in hodgkin's disease. is there an underlying imm... 1130195 - Infantile genetic agranulocytosis. a review with presentation of ten new cases. 11818045 - Metacercarial aggregation in digenea (fasciola hepatica and paramphistomum daubneyi): e... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Dermatology (Basel, Switzerland) Volume: 206 ISSN: 1018-8665 ISO Abbreviation: Dermatology (Basel) Publication Date: 2003 |
Date Detail:
|
Created Date: 2003-05-28 Completed Date: 2003-10-15 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9203244 Medline TA: Dermatology Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 330-3 Citation Subset: IM |
Copyright Information:
|
Copyright 2003 S. Karger AG, Basel |
Affiliation:
|
Dipartimento di Medicina Clinica e Sperimentale, Sezione di Dermatologia, Università di Ferrara, Italy. czm@unife.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antigens, CD30
/
blood* Cyclosporine / adverse effects*, therapeutic use Etretinate / therapeutic use Fatal Outcome Female Humans Immunosuppressive Agents / adverse effects*, therapeutic use Keratolytic Agents / therapeutic use Lymphoma, T-Cell, Cutaneous / chemically induced*, immunology, pathology Middle Aged Psoriasis / drug therapy* Risk Factors Skin Neoplasms / chemically induced*, immunology, pathology Tumor Markers, Biological / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, CD30; 0/Immunosuppressive Agents; 0/Keratolytic Agents; 0/Tumor Markers, Biological; 54350-48-0/Etretinate; 59865-13-3/Cyclosporine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Papulonodular mucinosis associated with subacute cutaneous lupus erythematosus.
Next Document: Transformation between Kaposiform hemangioendothelioma and tufted angioma.